{
  "schemaVersion" : 2,
  "registerId" : "F2017C00811",
  "instrumentNumber" : "39/2014",
  "citation" : "Statement of Principles concerning malignant neoplasm of the thyroid gland No. 39 of 2014",
  "conditionName" : "malignant neoplasm of the thyroid gland",
  "effectiveFrom" : "2014-05-07",
  "standardOfProof" : "Reasonable Hypothesis",
  "icdCodes" : [ {
    "version" : "ICD-10-AM",
    "code" : "C73"
  } ],
  "onsetFactors" : [ {
    "paragraph" : "6(a)",
    "text" : "having received a cumulative equivalent dose of at least 0.1 sievert of\r\nionising radiation to the thyroid gland at least five years before the\r\nclinical onset of malignant neoplasm of the thyroid gland",
    "definedTerms" : [ {
      "term" : "cumulative equivalent dose",
      "definition" : "means the total dose of ionising radiation\nreceived by the particular organ or tissue from external exposure, internal\nexposure or both, apart from normal background radiation exposure in\nAustralia, calculated in accordance with the methodology set out in Guide to\ncalculation of 'cumulative equivalent dose' for the purpose of applying\nionising radiation factors contained in Statements of Principles determined\nunder Part XIA of the Veterans' Entitlements Act 1986 (Cth), Australian\nRadiation Protection and Nuclear Safety Agency, as in force on 2 August\n2017;\nNote 1: Examples of circumstances that might lead to exposure to ionising radiation include\nbeing present during or subsequent to the testing or use of nuclear weapons,\nundergoing diagnostic or therapeutic medical procedures involving ionising radiation,\nand being a member of an aircrew, leading to increased levels of exposure to cosmic\nradiation.\nNote 2: For the purpose of dose reconstruction, dose is calculated as an average over the mass\nof a specific tissue or organ. If a tissue is exposed to multiple sources of ionising\nradiation, the various dose estimates for each type of radiation must be combined"
    } ]
  }, {
    "paragraph" : "6(b)",
    "text" : "having a specified disorder of the thyroid gland at least one year before\r\nthe clinical onset of malignant neoplasm of the thyroid gland",
    "definedTerms" : [ {
      "term" : "a specified disorder of the thyroid gland",
      "definition" : "means:\n(a) goitre (includes thyroid adenoma);\n(b) Graves' disease; or\n(c) Hashimoto's thyroiditis"
    } ]
  }, {
    "paragraph" : "6(c)",
    "text" : "being overweight or obese for a period of at least five years before the\r\nclinical onset of malignant neoplasm of the thyroid gland",
    "definedTerms" : [ {
      "term" : "being overweight or obese",
      "definition" : "means an increase in body weight by way of fat\naccumulation which results in a Body Mass Index (BMI) of 25 or greater.\n2\nThe BMI = W/H and where:\nW is the person's weight in kilograms; and\nH is the person's height in metres"
    } ]
  }, {
    "paragraph" : "6(d)",
    "text" : "undergoing stem cell, bone marrow or solid organ transplantation\r\nbefore the clinical onset of malignant neoplasm of the thyroid gland",
    "definedTerms" : [ ]
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "6(e)",
    "text" : "inability to obtain appropriate clinical management for malignant\r\nneoplasm of the thyroid gland",
    "definedTerms" : [ ]
  } ]
}